Cost-effectiveness of nurse-led self-help for recurrent depression in the primary care setting: Design of a pragmatic randomised controlled trial

BMC Psychiatry

Volumn 12, Issue , 2012, Pages

  Biesheuvel Leliefeld, Karolien E M ^a   Kersten, Sandra M A ^a   van der Horst, Henriette E ^a   van Schaik, Anneke ^a   Bockting, Claudi L H ^b   Bosmans, Judith E ^c   Smit, Filip ^a,d   van Marwijk, Harm W J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

Author keywords

Cognitive therapy; Design; Major depressive disorder; Prevention; Primary care; Randomised controlled trial; Recurrence; Relapse

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; DSM-IV; FATIGUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; NURSE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PATIENT CARE; PRIMARY MEDICAL CARE; PSYCHOPHARMACOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; RISK REDUCTION; SELF CONCEPT; SELF HELP; TREATMENT RESPONSE; COST UTILITY ANALYSIS; DEPRESSION; ECONOMIC EVALUATION; MENTAL DISEASE; ONSET AGE; PREVENTIVE COGNITIVE THERAPY; RECURRENCE RISK; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

ADOLESCENT; ADULT; AGED; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; HUMANS; MIDDLE AGED; PRIMARY HEALTH CARE; RESEARCH DESIGN; SELF CARE;

EID: 84861896209     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-12-59     Document Type: Article

References (67)

1. Murray CJ, Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet 1997, 349:1347-1352. 10.1016/S0140-6736(96)07494-6, 9149696.
2. Ormel J, Petukhova M, Chatterji S, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Bromet EJ, Burger H, Demyttenaere K. de GG et al.: Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry 2008, 192:368-375. 10.1192/bjp.bp.107.039107, 2681238, 18450663.
3. Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry 2004, 61:1097-1103. 10.1001/archpsyc.61.11.1097, 15520357.
4. Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, Warshaw M, Maser JD. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999, 156:1000-1006.
5. Paykel ES. Continuation and maintenance therapy in depression. Br Med Bull 2001, 57:145-159. 10.1093/bmb/57.1.145, 11719914.
6. Van Loenen AC. Farmacotherapeutisch kompas 2003, , .
7. Viguera AC, Baldessarini RJ, Friedberg J. Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry 1998, 5:293-306. 10.3109/10673229809003578, 9559348.
8. Piek E, van der Meer K, Nolen WA. Guideline recommendations for long-term treatment of depression with antidepressants in primary care-a critical review. Eur J Gen Pract 2010, 16:106-112. 10.3109/13814781003692463, 20297924.
9. Kaymaz N. van OJ, Loonen AJ, Nolen WA: Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 2008, 69:1423-1436. 10.4088/JCP.v69n0910, 19193343.
10. van Schaik DJ, Klijn AF, van Hout HP, van Marwijk HW, Beekman AT. de HM, van DR: Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry 2004, 26:184-189. 10.1016/j.genhosppsych.2003.12.001, 15121346.
11. Bockting CL, ten Doesschate MC, Spijker J, Spinhoven P, Koeter MW, Schene AH. Continuation and maintenance use of antidepressants in recurrent depression. Psychother Psychosom 2008, 77:17-26. 10.1159/000110056, 18087204.
12. Meijer WE, Heerdink ER, Leufkens HG, Herings RM, Egberts AC, Nolen WA. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 2004, 60:57-61. 10.1007/s00228-004-0726-3, 14985889.
13. ten Doesschate MC, Bockting CL, Koeter MW, Schene AH. Predictors of nonadherence to continuation and maintenance antidepressant medication in patients with remitted recurrent depression. J Clin Psychiatry 2009, 70:63-69. 10.4088/JCP.08m04119, 19192463.
14. Möller HJ, Riedel M, Seemüller F. Relapse or recurrence in depression: why has the cutoff been set at 6 months?. Medicographia 2011, 33:125-131.
15. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991, 48:851-855. 10.1001/archpsyc.1991.01810330075011, 1929776.
16. Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2009, 11:453-473. 10.1111/j.1399-5618.2009.00726.x, 19624385.
17. Hollon SD, Ponniah K. A review of empirically supported psychological therapies for mood disorders in adults. Depress Anxiety 2010, 27:891-932. 10.1002/da.20741, 2948609, 20830696.
18. Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves GG, Silver PC. Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Arch Gen Psychiatry 2001, 58:381-388. 10.1001/archpsyc.58.4.381, 1307495, 11296099.
19. Vittengl JR, Clark LA, Dunn TW, Jarrett RB. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol 2007, 75:475-488. 2630051, 17563164.
20. Bockting CL, Spinhoven P, Wouters LF, Koeter MW, Schene AH. Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study. J Clin Psychiatry 2009, 70:1621-1628. 10.4088/JCP.08m04784blu, 20141705.
21. Bockting CL, Schene AH, Spinhoven P, Koeter MW, Wouters LF, Huyser J, Kamphuis JH. Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial. J Consult Clin Psychol 2005, 73:647-657.
22. Bijl RV, Ravelli A. Psychiatrische morbididteit, zorggebruik en zorgbehoefte. Resultaten van de Netherlands Mental Health Survey and Incidence Study. Tijdschrift voor Gezondheidswetenschappen 1998, 76:446-57.
23. den Boer PC, Wiersma D, Van den Bosch RJ. Why is self-help neglected in the treatment of emotional disorders? A meta-analysis. Psychol Med 2004, 34:959-971. 10.1017/S003329170300179X, 15554567.
24. Gregory RJ, Canning SS, Lee TW, Wise JC. Cognitive bibliotherapy for depression: A meta-analysis. Professional Psychology-Research and Practice 2004, 35:275-280.
25. McKendree-Smith NL, Floyd M, Scogin FR. Self-administered treatments for depression: a review. J Clin Psychol 2003, 59:275-288. 10.1002/jclp.10129, 12579545.
26. Van't Hof E, Cuijpers P, Stein DJ. Self-help and Internet-guided interventions in depression and anxiety disorders: a systematic review of meta-analyses. CNS Spectr 2009, 14:34-40.
27. Marrs RW. A meta-analysis of bibliotherapy studies. Am J Community Psychol 1995, 23:843-870. 10.1007/BF02507018, 8638553.
28. Newman MG, Erickson T, Przeworski A, Dzus E. Self-help and minimal-contact therapies for anxiety disorders: Is human contact necessary for therapeutic efficacy?. J Clin Psychol 2003, 59:251-274. 10.1002/jclp.10128, 12579544.
29. Spek V, Cuijpers P, Nyklicek I, Riper H, Keyzer J, Pop V. Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol Med 2007, 37:319-328. 10.1017/S0033291706008944, 17112400.
30. Hunkeler EM, Meresman JF, Hargreaves WA, Fireman B, Berman WH, Kirsch AJ, Groebe J, Hurt SW, Braden P, Getzell M, et al. Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch Fam Med 2000, 9:700-708. 10.1001/archfami.9.8.700, 10927707.
31. Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000, 320:26-30. 10.1136/bmj.320.7226.26, 27250, 10617523.
32. First MB, Gibbon M, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders 1996, American Psychiatric Press, Inc, Washington, D.C.
33. Joling KJ, van Marwijk HW, Piek E, van der Horst HE, Penninx BW, Verhaak P, van Hout HP. Do GPs' medical records demonstrate a good recognition of depression? A new perspective on case extraction. J Affect Disord 2011, 133:522-527. 10.1016/j.jad.2011.05.001, 21605910.
34. Bockting CL, Spinhoven P, Huibers MJ, . Edited by Richards S, Perry M Relapse prevention in recurrent depression using CBT 2010, American Psychological Association, Washington D.C, Edited by Richards S, Perry M.
35. Van Marwijk HWJ, Grundmeijer HGLM, Bijl D, Van Gelderen MG, De Haan M, Van Weel-Baumgarten EM, Burgers JS, Boukes FS, Romeijnders ACM. NHG-Standaard Depressieve stoornis (depressie) (Eerste herziening). Huisarts & Wetenschap 2003, 46:614-633. 10.1007/BF03083439, 22393819.
36. Hakkaart-van Roijen L, Van Straten A, Donker M, et al. Manual:Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric Illness (in Dutch) 2002, Rotterdam, Erasmus University.
37. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74. 10.1097/00005650-198601000-00007, 3945130.
38. Smelt AF, van der Weele GM, Blom JW, Gussekloo J, Assendelft WJ. How usual is usual care in pragmatic intervention studies in primary care? An overview of recent trials. Br J Gen Pract 2010, 60:e305-e318. 2894405, 20594432.
39. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000, 68:615-623.
40. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol 2004, 72:31-40.
41. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003, 54:573-583. 10.1016/S0006-3223(02)01866-8, 12946886.
42. EuroQol group EuroQol - a new facility for the measurement of health-related quality of life 1990, 199-208. The EuroQol Group, Health Policy, EuroQol group.
43. Ware J. Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233. 10.1097/00005650-199603000-00003, 8628042.
44. Terluin B, van Marwijk HW, Ader HJ, de Vet HC, Penninx BW, Hermens ML, van Boeijen CA, van Balkom AJ, van der Klink JJ, Stalman WA. The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. BMC Psychiatry 2006, 6:34. 10.1186/1471-244X-6-34, 1590008, 16925825.
45. Schwarzer R, Jerusalem M. Generalized Self-Efficacy scale 1995, 35-37. Causal and control beliefs. Edited by Weinman J, Wright S, Johnston M, Windsor, UK.
46. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46:1121-1123. 10.1001/archneur.1989.00520460115022, 2803071.
47. van der Kloot WA, Oostendorp RA. van der MJ, van den HJ: [The Dutch version of the McGill pain questionnaire: a reliable pain questionnaire]. Ned Tijdschr Geneeskd 1995, 139:669-673.
48. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann 1979, 2:197-207. 10.1016/0149-7189(79)90094-6, 10245370.
49. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC, American Psychiatric Association.
50. Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ. Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff. Ned Tijdschr Geneeskd 2005, 149:1574-1578.
51. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004, 42:851-859. 10.1097/01.mlr.0000135827.18610.0d, 15319610.
52. Le LA, Despiegel N, Francois C, Duru G. Can discrete event simulation be of use in modelling major depression?. Cost Eff Resour Alloc 2006, 4:19. 10.1186/1478-7547-4-19, 1762026, 17147790.
53. Penninx BW, Nolen WA, Lamers F, Zitman FG, Smit JH, Spinhoven P, Cuijpers P, de Jong PJ, van Marwijk HW, der Meer KV, et al. Two-year course of depressive and anxiety disorders: Results from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord 2011, 133(1-2):76-85.
54. Paykel ES. Partial remission, residual symptoms, and relapse in depression. Dialogues Clin Neurosci 2008, 10:431-437. 3181895, 19170400.
55. Van Voorhees BW, Paunesku D, Kuwabara SA, Basu A, Gollan J, Hankin BL, Melkonian S, Reinecke M. Protective and vulnerability factors predicting new-onset depressive episode in a representative of U.S. adolescents. J Adolesc Health 2008, 42:605-616. 10.1016/j.jadohealth.2007.11.135, 18486870.
56. Geerlings SW, Twisk JW, Beekman AT, Deeg DJ. van TW: Longitudinal relationship between pain and depression in older adults: sex, age and physical disability. Soc Psychiatry Psychiatr Epidemiol 2002, 37:23-30. 10.1007/s127-002-8210-2, 11926200.
57. Skapinakis P, Lewis G, Mavreas V. Temporal relations between unexplained fatigue and depression: longitudinal data from an international study in primary care. Psychosom Med 2004, 66:330-335. 10.1097/01.psy.0000124757.10167.b1, 15184691.
58. Segal ZV, Kennedy S, Gemar M, Hood K, Pedersen R, Buis T. Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. Arch Gen Psychiatry 2006, 63:749-755. 10.1001/archpsyc.63.7.749, 16818864.
59. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor kostenonderzoek 2010, Instituut voor Medical Technology Assessment iov CZV, Rotterdam.
60. Oostenbrink JB, Koopmanschap MA, Rutten C. Standardisation of Costs 2002, The Dutch Manual for Costing in Economic Evaluations, Adis International.
61. Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ 1995, 14:171-189. 10.1016/0167-6296(94)00044-5, 10154656.
62. Boston RC, Sumner AE. STATA: a statistical analysis system for examining biomedical data. Adv Exp Med Biol 2003, 537:353-369. 10.1007/978-1-4419-9019-8_23, 14995047.
63. Cohen SB. An evaluation of alternative PC-based software packages developed for the analysis of complex survey data. The American Statistician 1997, 51:285-292.
64. Van Buuren S, Oudshoorn CGM. Multivariate imputation by chained equations 2000, MICE V1.0 user's manual. Leiden, TNO Preventie en Gezondheid.
65. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed?. BMJ 2000, 320:1197-1200. 10.1136/bmj.320.7243.1197, 1127588, 10784550.
66. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ 2004, 13:405-415. 10.1002/hec.903, 15127421.
67. Hoch JS, Rockx MA, Krahn AD. Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope. BMC Health Serv Res 2006, 6:68. 10.1186/1472-6963-6-68, 1543623, 16756680.